共 50 条
- [21] RANDOMIZED CLINICAL-TRIAL OF DOXORUBICIN ALONE OR COMBINED WITH MITOLACTOL IN WOMEN WITH ADVANCED BREAST-CANCER AND PRIOR CHEMOTHERAPY EXPOSURE AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1985, 8 (04): : 275 - 282
- [24] PHASE-II CLINICAL-TRIAL OF ACIVICIN IN ADVANCED BREAST-CANCER - AN EASTERN COOPERATIVE ONCOLOGY GROUP-STUDY CANCER TREATMENT REPORTS, 1986, 70 (10): : 1237 - 1238
- [25] WEEKLY EPIRUBICIN VERSUS DOXORUBICIN AS 2ND LINE THERAPY IN ADVANCED BREAST-CANCER - A RANDOMIZED CLINICAL-TRIAL AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (01): : 38 - 44
- [26] RANDOMIZED CLINICAL-TRIAL OF CYCLOPHOSPHAMIDE, 5-FU, AND PREDNISONE WITH OR WITHOUT TAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER CANCER TREATMENT REPORTS, 1985, 69 (04): : 355 - 361
- [27] A CONTROLLED CLINICAL-TRIAL ON ADJUVANT THERAPY BY PREOPERATIVE IRRADIATION OR POSTOPERATIVE CYCLOPHOSPHAMIDE IN BREAST-CANCER ARCHIV FUR GESCHWULSTFORSCHUNG, 1980, 50 (05): : 468 - 479
- [28] 34 YEAR FOLLOW UP OF PATIENTS WITH BREAST-CANCER IN CLINICAL-TRIAL OF POSTOPERATIVE RADIOTHERAPY BRITISH MEDICAL JOURNAL, 1985, 291 (6502): : 1088 - 1091
- [29] CLINICAL-TRIAL OF COMBINED HORMONE-THERAPY (MAP + TAM) FOR METASTATIC BREAST-CANCER CHEMIOTERAPIA, 1984, 3 (04): : 211 - 215
- [30] PHYSICIANS REASONS FOR NOT ENTERING ELIGIBLE PATIENTS IN A RANDOMIZED CLINICAL-TRIAL OF SURGERY FOR BREAST-CANCER NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (21): : 1363 - 1367